Orange Book product · Generic (ANDA)
CEFPROZIL
CEFPROZIL
At a glance
Dec 19, 2005
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 2005
20 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFPROZIL
Strength
250MG/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
AB
Application
ANDA 065261
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of CEFPROZIL
- 1991CEFZILBrand (NDA)
NDA 050665 · CORDEN PHARMA
- 1991CEFZILBrand (NDA)
NDA 050664 · CORDEN PHARMA
- 2024CEFPROZILGeneric (ANDA)
ANDA 090857 · ALKEM LABS LTD
- 2012CEFPROZILGeneric (ANDA)
ANDA 065351 · APOTEX INC
- 2008CEFPROZILGeneric (ANDA)
ANDA 065327 · APOTEX INC
- 2007CEFPROZILGeneric (ANDA)
ANDA 065428 · WOCKHARDT
- 2007CEFPROZILGeneric (ANDA)
ANDA 065340 · AUROBINDO PHARMA
- 2007CEFPROZILGeneric (ANDA)
ANDA 065381 · AUROBINDO PHARMA
- 2006CEFPROZILGeneric (ANDA)
ANDA 065198 · RANBAXY LABS LTD
- 2006CEFPROZILGeneric (ANDA)
ANDA 065202 · RANBAXY LABS LTD
- 2005CEFPROZILGeneric (ANDA)
ANDA 065284 · ORCHID HLTHCARE
- 2005CEFPROZILGeneric (ANDA)
ANDA 065267 · ORCHID HLTHCARE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
